PrairieView Partners’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$47K Sell
1,964
-1,195
-38% -$27.9K ﹤0.01% 193
2025
Q1
$80K Buy
3,159
+1,018
+48% +$26.6K 0.01% 166
2024
Q4
$56K Hold
2,141
0.01% 191
2024
Q3
$61K Hold
2,141
0.01% 182
2024
Q2
$59K Sell
2,141
-20
-0.9% -$551 0.01% 190
2024
Q1
$60K Sell
2,161
-71
-3% -$1.97K 0.01% 174
2023
Q4
$64K Sell
2,232
-299
-12% -$9.04K 0.01% 164
2023
Q3
$83K Sell
2,531
-2,898
-53% -$102K 0.01% 143
2023
Q2
$199K Sell
5,429
-31
-0.6% -$1.21K 0.03% 116
2023
Q1
$222K Sell
5,460
-363
-6% -$15.7K 0.03% 107
2022
Q4
$298K Buy
5,823
+306
+6% +$14.7K 0.04% 88
2022
Q3
$241K Sell
5,517
-193
-3% -$9.38K 0.04% 90
2022
Q2
$299K Buy
5,710
+207
+4% +$10.5K 0.05% 86
2022
Q1
$285K Buy
5,503
+100
+2% +$5.19K 0.04% 89
2021
Q4
$319K Sell
5,403
-1,589
-23% -$78.7K 0.04% 80
2021
Q3
$301K Buy
6,992
+13
+0.2% +$576 0.04% 80
2021
Q2
$273K Buy
6,979
+16
+0.2% +$622 0.04% 80
2021
Q1
$252K Buy
6,963
+17
+0.2% +$604 0.04% 80
2020
Q4
$256K Sell
6,946
-152
-2% -$5.58K 0.05% 74
2020
Q3
$247K Buy
7,098
+14
+0.2% +$491 0.05% 70
2020
Q2
$220K Buy
7,084
+15
+0.2% +$510 0.05% 68
2020
Q1
$219K Buy
7,069
+225
+3% +$7.67K 0.06% 72
2019
Q4
$254K Sell
6,844
-19
-0.3% -$677 0.05% 74
2019
Q3
$234K Buy
+6,863
New +$250K 0.05% 76
2018
Q2
Sell
-6,702
Closed -$226K 62
2018
Q1
$226K Buy
6,702
+12
+0.2% +$413 0.05% 64
2017
Q4
$230K Buy
+6,690
New +$228K 0.06% 62

Other funds holding PFE

PrairieView Partners's PFE Position: Q2 2025 in Review

PrairieView Partners reduced its Pfizer (PFE) stake by 38% in Q2 2025, selling an estimated $27.9K and leaving 1,964 shares worth $47K. The position accounts for ﹤0.01% of the portfolio, ranked #193.

PrairieView Partners first reported a position in PFE in Q4 2017 and has held it in 26 quarters since. The position peaked at $319K in Q4 2021. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

  • PrairieView Partners held 1,964 shares of Pfizer worth $47K as of Q2 2025.
  • PrairieView Partners sold 1,195 Pfizer shares in Q2 2025, an estimated $27.9K.
  • Pfizer made up ﹤0.01% of PrairieView Partners's portfolio in Q2 2025, its #193 holding.
  • PrairieView Partners first reported a position in Pfizer in Q4 2017 and has held it in 26 quarters since.
  • PrairieView Partners's Pfizer position peaked at $319K in Q4 2021.
  • 2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on PrairieView Partners's 13F filing for Q2 2025, filed 25 Jul 2025.